| Ms Amy Lynn Smart, PA-C | |
|
6 Business Park Dr Ste 302, Branford, CT 06405-2988 | |
| (203) 483-4580 | |
| Not Available |
| Full Name | Ms Amy Lynn Smart |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 19 Years |
| Location | 6 Business Park Dr Ste 302, Branford, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598043804 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 3663 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yale-new Haven Hospital | New haven, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
Arrayit Corporation announced today that the new High Throughput Biology Center at Johns Hopkins University School of Medicine in Baltimore Maryland purchased Arrayit's proprietary technology to create a Human Proteome Chip to discover biomarkers for autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, autoimmune hepatitis (first identified by Dr. Zhu), lupus, and others.
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
Somanetics Corporation today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba coreFoundry"). Under terms of the agreement, Somanetics has obtained exclusive rights, subject to specified rights of the U.S. Government and rights retained by The Johns Hopkins University, to new cerebral autoregulation technology developed at The Johns Hopkins University.
US-Australian drug discovery company, Novogen Limited, today announced that it has received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Amy Lynn Smart, PA-C 1918 Black Rock Tpke, Fairfield, CT 06825-3543 Ph: (413) 834-0405 | Ms Amy Lynn Smart, PA-C 6 Business Park Dr Ste 302, Branford, CT 06405-2988 Ph: (203) 483-4580 |
News Archive
Arrayit Corporation announced today that the new High Throughput Biology Center at Johns Hopkins University School of Medicine in Baltimore Maryland purchased Arrayit's proprietary technology to create a Human Proteome Chip to discover biomarkers for autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, autoimmune hepatitis (first identified by Dr. Zhu), lupus, and others.
Aegera Therapeutics Inc. released today encouraging survival data from the Phase 1 portion of its Phase 1-2 Study of the novel targeted therapeutic, AEG35156, given in combination with sorafenib in patients with advanced hepatocellular carcinoma (primary liver cancer).
Somanetics Corporation today announced that it has signed an Exclusive Sublicense Agreement with Raba Equity Partners II, LLC ("Raba coreFoundry"). Under terms of the agreement, Somanetics has obtained exclusive rights, subject to specified rights of the U.S. Government and rights retained by The Johns Hopkins University, to new cerebral autoregulation technology developed at The Johns Hopkins University.
US-Australian drug discovery company, Novogen Limited, today announced that it has received notification from the U.S. Food and Drug Administration that its chemotherapy candidate drug, Anisina, has been granted Orphan Drug Designation for neuroblastoma.
Venture capitalists and Wall Street have invested millions of dollars to capitalize on the health care industry's burgeoning demand for information technology. But in New York State, the push to automate the Medicaid enrollment process is being led not by a behemoth IT corporation, but by a tiny not-for-profit: the Hudson Center for Health Equity & Quality (Hudson Center). And 2012 is shaping up to be its breakout year.
› Verified 9 days ago
Lea Murphy, Physician Assistant Medicare: Medicare Enrolled Practice Location: 960 Main St, Branford, CT 06405 Phone: 203-488-6358 | |
Ellen Majors, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6 Business Park Dr, Suite 302, Branford, CT 06405 Phone: 203-483-4580 Fax: 203-483-4581 | |
Mr. Michael A Vargas, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 84 N Main St Bldg 2, Branford, CT 06405 Phone: 203-483-2024 Fax: 203-483-2520 | |
Sarah Clark, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 960 Main St, Branford, CT 06405 Phone: 203-488-6358 Fax: 203-481-5327 | |
Dana Ann Chateauneuf, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 84 N Main St, Branford, CT 06405 Phone: 203-483-2509 Fax: 203-483-2513 | |
Mr. William Michael Shafnacker, PAC MHP Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 6 Business Park Dr Ste 302, Stony Creek Urgent Care, Branford, CT 06405 Phone: 203-483-4580 Fax: 203-483-4581 |